RFICs

WHITE PAPERS AND CASE STUDIES

• Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial

  Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.

• Pasteurized Equivalent Water Treatment At High Desert Milk, Idaho, US

  Learn how High Desert Milk, a cooperative in Idaho, optimized their water treatment process using HOD™ UV technology, ensuring FDA compliance while significantly reducing water and energy consumption.

• Coordinating Global Capabilities To Support A Gene Therapy

  Discover how our integrated expertise in GLP toxicology, biodistribution, and CMC services helped a biotech company secure IND approval for a groundbreaking gene therapy.

• BSL-3 Mobile Biocontainment Laboratory For Vaccine Development Research

  The client required a freestanding COVID-19 research facility on an accelerated timeline built for continuous use in the cold climate of the northeast United States without a shell building.

• Pumping And Network Operations Optimized Through Collaborative Digital Twins

  Collaborative digital twins streamline utility operations by integrating real-time data into a shared, intuitive environment. This approach enables precise pump optimization, efficient maintenance scheduling, and proactive network simulations to improve water quality and system resilience.

• 82 Million Gallons In. Zero PFAS Out.

  Ion exchange resin is a reliable, high-capacity solution for municipal PFAS treatment, demonstrating zero detectable PFAS after processing 82 million gallons of water. The technology offers a significantly smaller footprint and superior volumetric capacity compared to GAC. Read the full case study to review performance data and strategic impacts.

• Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches

  Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).

• Enabling MSC Harvest, Wash, And Concentration

  A study demonstrates how a low-shear, closed-system centrifuge achieved over 90% MSC recovery and minimized viability loss, supporting scalable cell therapy manufacturing.

• Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting

  Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.

• Unravelling Immunological Depths: Exploring Oxazolone-Induced Delayed-Type Hypersensitivity Model

  Validating the oxazolone-induced DTH mouse model offers a critical platform for advancing the evaluation of therapeutic candidates for chronic inflammatory diseases, including atopic dermatitis.

• A Pre-Clinical Study For Diet-Induced Obesity

  Here, we look at the importance of using high-fat diet-induced obesity models to evaluate and compare the efficacy of anti-obesity and anti-diabetic treatments like rimonabant and liraglutide.

• SYLOID® Silica For Enhanced Micronization Efficiency

  Here, we demonstrate how adding small amounts of SYLOID® mesoporous silica to Cholesterol before jet milling can enhance processing efficiency, boost yield, and improve micronization performance.